Welcome to CDC Stacks | Recommendations for early empiric antiviral treatment in persons with suspected influenza who are at increased risk of developing severe disease - 25210 | Health Alert Network (HAN)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Recommendations for early empiric antiviral treatment in persons with suspected influenza who are at increased risk of developing severe disease
  • Published Date:
    10/19/09
  • Source:
    HAN ; 299
  • Language:
    English
Filetype[PDF - 746.49 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Influenza antiviral use for persons at high risk for influenza complications or who have severe influenza illness
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    2/29/08
    Source:
    HAN ; 271
    Series:
    HAN ; 271
    Description:
    Friday, February 29, 2008, 14:10 EST (02:10 PM EST) : CDCHAN-00271-2008-02-29-ADV-N : CDC is alerting clinicians to be fully aware o f the potential benefits o f influenza antiviral medications during this influenza season.
    File Type:
    Filetype[PDF - 47.83 KB]
  2. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease.
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.
    Published:
    September 25, 2009
    Source:
    MMWR. Morbidity and mortality weekly report. 2009; 58(37):1042-3.
    Description:
    The Advisory Committee on Immunization Practices (ACIP) recommends quadrivalent meningococcal conjugate vaccine, (MCV4) (Menactra, Sanofi Pasteur, Swiftwater, Pennsylvania) for all persons aged 11-18 years and for persons aged 2-55 years at increased...
    Status:
    superseded
    File Type:
    Filetype[PDF - 1.49 MB]
  3. Flu season begins : severe influenza illness reported : CDC urges rapid antiviral treatment of very ill and high risk suspect influenza patients without waiting for testing
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    February 1, 2016,
    Series:
    HAN ; 387
    Description:
    February 1, 2016, 0850 EST (8:50 AM EST) : CDCHAN-00387 : Influenza activity is increasing across the country and CDC has received reports of severe influenza illness. Clinicians are reminded to treat suspected influenza in high-risk outpatients, tho...
    File Type:
    Filetype[PDF - 157.52 KB]
  4. Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis
    Personal Author:
    Secor, Virginia H.; Secor, W. Evan; Gutekunst, Claire-Anne; Brown, Melissa A.;
    Published:
    Mar 6 2000
    Source:
    J Exp Med. 2000; 191(5):813-822.
    Description:
    In addition to their well characterized role in allergic inflammation, recent data confirm that mast cells play a more extensive role in a variety of immune responses. However, their contribution to autoimmune and neurologic disease processes has not...
    File Type:
    Filetype[PDF - 247.98 KB]
  5. CDC guidance on antiviral treatment of patients with confirmed, probable, or suspected cases of novel influenza A (H1N1)
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    5/27/09
    Source:
    HAN ; 293
    Series:
    HAN ; 293
    Description:
    Wednesday, May 27, 2009, 11:30 EDT (11:30 AM EDT) : CDCHAN-00293-2009-05-27-UPD-N : As a reminder to clinicians, this Health Update summarizes existing CDC guidance issued on May 6, 2009 on the use of antiviral drugs in novel H1N1 patients and their ...
    File Type:
    Filetype[PDF - 28.51 KB]